GlassScriptPhysician profile
Bryan Biondi
NPI 1356071104
$974.72
in general payments reported to CMS, 2019-2025
18 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $337 · 2024: $307 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.74 | 2022-2025 | |
| Vertos Medical, INC. | $93.75 | 2023 | Mild Device Kit |
| Nevro Corp. | $79.68 | 2023-2024 | Senza |
| Painteq LLC | $70.84 | 2024 | Painteq |
| Medtronic, INC. | $70.45 | 2024-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Lilly USA, LLC | $50.80 | 2023 | Emgality, Reyvow |
| Djo, LLC | $48.78 | 2024 | Cmf |
| Spr Therapeutics, INC | $46.66 | 2024 | Sprint Pns System |
| Boston Scientific Corporation | $39.94 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $34.03 | 2024 | Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $31.76 | 2025 | |
| Averitas Pharma INC. | $24.45 | 2023 | Qutenza |
| Relievant Medsystems, INC. | $24.45 | 2022 | |
| Saluda Medical Americas, INC. | $24.35 | 2025 | Evoke |
| Curonix LLC | $23.62 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.51 | 2025 | Vyepti |
| Azurity Pharmaceuticals, INC. | $16.12 | 2025 | Horizant |
| Depuy Synthes Sales INC. | $15.79 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Biondi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.